Status:

UNKNOWN

Assessing Colonic Folate Absorption & Metabolism

Lead Sponsor:

The Hospital for Sick Children

Collaborating Sponsors:

Natural Sciences and Engineering Research Council, Canada

Conditions:

Folate

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Folate, a B-vitamin, is necessary in metabolic processes such as amino acid and nucleotide synthesis. Since folate cannot be synthesized by mammals, it must be consumed as foods and dietary supplement...

Detailed Description

The vitamin folate is necessary for one-carbon metabolism in processes such as amino acid and nucleotide synthesis. As folate cannot be synthesized by mammals, it must be sourced from the diet and die...

Eligibility Criteria

Inclusion

  • Males \>18 years old and \<75 years old;
  • Females who are pre-menopausal that have had a hysterectomy or tubal ligation, post-menopausal (at least 1 year) and \<75 years old;
  • Describe themselves as generally healthy.
  • Recommended to have a colonoscopy examination by their Doctor

Exclusion

  • They have a history of gastrointestinal disease (such as Crohn's disease, ulcerative colitis, celiac disease) and/ or gastrointestinal cancers;
  • They have had a previous colon resection;
  • They are regularly using medications that may affect gastrointestinal pH or folate metabolism (e.g. proton pump inhibitors, phenytoin, phenobarbital, primidone, or have used oral antibiotics within the last 2 weeks);
  • On a regular basis they consume \>2 alcoholic drinks/day for women or \>3/day for men;
  • They are currently smokers;
  • They are folic acid supplement users or have used folic acid supplements or multivitamins containing folic acid in the last 4 months;
  • They have a bleeding disorder (such as hemophilia)
  • They are unlikely able to discontinue anti-coagulant therapy prior to colonoscopy

Key Trial Info

Start Date :

December 17 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 15 2023

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT03421483

Start Date

December 17 2018

End Date

October 15 2023

Last Update

October 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Michael's Hospital

Toronto, Ontario, Canada, M5B 1W8